The Expression of microRNAs and Their Involvement in Recurrent Pregnancy Loss
-
Published:2024-06-07
Issue:12
Volume:13
Page:3361
-
ISSN:2077-0383
-
Container-title:Journal of Clinical Medicine
-
language:en
-
Short-container-title:JCM
Author:
Patronia Maria-Markella1, Potiris Anastasios2ORCID, Mavrogianni Despoina1, Drakaki Eirini1, Karampitsakos Theodoros2ORCID, Machairoudias Pavlos2, Topis Spyridon2, Zikopoulos Athanasios2, Vrachnis Dionysios2ORCID, Moustakli Efthalia3ORCID, Skentou Chara4, Domali Ekaterini1, Vrachnis Nikolaos2ORCID, Drakakis Peter2, Stavros Sofoklis2
Affiliation:
1. First Department of Obstetrics and Gynecology, Alexandra Hospital, Medical School, National and Kapodistrian University of Athens, 11528 Athens, Greece 2. Third Department of Obstetrics and Gynecology, University General Hospital “ATTIKON”, Medical School, National and Kapodistrian University of Athens, 12462 Athens, Greece 3. Laboratory of Medical Genetics, Faculty of Medicine, School of Health Sciences, University of Ioannina, 45110 Ioannina, Greece 4. Department of Obstetrics and Gynecology, Medical School of the University of Ioannina, 45110 Ioannina, Greece
Abstract
Background: Recurrent pregnancy loss refers to the spontaneous demise of two or more pregnancies before the 24 weeks of gestation. In almost half of the cases of recurrent miscarriages, the causes remain unknown since there is no reliable way of prognosis, early diagnosis, or treatment. Recent research has detected differential expression of certain miRNAs in reproductive system pathologies. Methods: The aim of the present review is to focus on microRNAs and their relationship with idiopathic recurrent miscarriages and to correlate miRNA expression with recurrent miscarriage and examine their potential role as biomarkers. Pubmed/Medline and Scopus databases were searched up to 31st January 2024 with terms related to recurrent pregnancy loss and miRNAs. Results: In total, 21 studies were selected for the review. A total of 75 different miRNAs were identified, showing a statistically significant differential expression. Around 40 miRNAs had increased expression, such as miR-520, miR-184 and miR-100-5p, 21 decreased, such as let-7c, and 14 had either increased or decreased expression depending on the study, such as miR-21. Conclusions: The dysregulation of miRNA expression is strongly associated with recurrent miscarriages. The circulating in the peripheral blood miRNAs, miR-100-5p and let-7c, might be utilized as biomarkers and establish a valuable non-invasive prognostic and diagnostic tool in the future.
Reference43 articles.
1. ESHRE Guideline Group on RPL, Bender Atik, R., Christiansen, O.B., Elson, J., Kolte, A.M., Lewis, S., Middeldorp, S., McHeik, S., Peramo, B., and Quenby, S. (2023). ESHRE guideline: Recurrent pregnancy loss: An update in 2022. Hum. Reprod. Open, 2023, hoad002. 2. Practice Committee of the American Society for Reproductive Medicine (2012). Evaluation and treatment of recurrent pregnancy loss: A committee opinion. Fertil. Steril., 98, 1103–1111. 3. Miscarriage matters: The epidemiological, physical, psychological, and economic costs of early pregnancy loss;Quenby;Lancet,2021 4. Effects of endocrine disrupting compounds on female fertility;Panagopoulos;Best. Pract. Res. Clin. Obstet. Gynaecol.,2023 5. Potiris, A., Perros, P., Drakaki, E., Mavrogianni, D., Machairiotis, N., Sfakianakis, A., Karampitsakos, T., Vrachnis, D., Antonakopoulos, N., and Panagopoulos, P. (2024). Investigating the Association of Assisted Reproduction Techniques and Adverse Perinatal Outcomes. J. Clin. Med., 13.
|
|